Stocktoria

PETMED EXPRESS INC PETS

Nasdaq · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2000-04-06 · LEI

PETMED EXPRESS INC (PETS) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 0.06% (safety: safe). FY2026 revenue was $179.0M at a -32.0% net margin.

Chart by TradingView
12/100
Stocktoria Quality Score · grade D
2/9
Piotroski F — financial health
-4.59
Altman Z″ — distress risk · distress
5.6%
Dividend yield 5y avg · safe · Dividend payout 0.0%
-4.64
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
3 6 4 4 4 3 4 4 5 2 2017201820192020202120222023202420252026
Altman Z″
13.46 15.77 16.33 13.80 10.59 11.52 6.89 3.27 3.51 -4.59 2017201820192020202120222023202420252026

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$2.01 as of 2026-08-01 · -34.5% 1y
$1.75$3.2052-wk

Beneish M-score: -4.64 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$38M
Dividend yield 5y avg5.6%
Net margin 5y avg-5.7%
Return on equity 5y avg-38.6%
Beta0.77
Employees189

Analyst price target

$2.15 +7% vs last
· 1 analysts
target range $2.15 – $2.15

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Smart money · insiders, last 12 months

Insiders net bought +$43,725 on the open market · 1 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · down

How it ranks in Retail Trade · percentile among 238 companies

Piotroski Fstronger than 3%
Net marginstronger than 11%
Return on equitystronger than 5%
Revenue growthstronger than 7%

Percentile vs other Retail Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 2/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets-0.104
Retained earnings / assets0.114
EBIT / assets-0.723
Equity / liabilities0.554

Sector peers · similar-size Retail Trade companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
PETSPETMED EXPRESS INC2/9-4.59-21.1%
RDGTRidgetech Inc.6/90.16+10.2%
CANNTREES Corp (Colorado)3/9-16.65+34.9%
GRDNGuardian Pharmacy Services, Inc.6/93.8554.4+17.9%
YI111, Inc.2/9-5.73-9%
CVSCVS HEALTH Corp5/90.9975.3+7.8%
WMTWalmart Inc.6/92.0144+4.7%

All Retail Trade companies →

About PETMED EXPRESS INC

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

FAQ

Is PETS financially healthy?

PETMED EXPRESS INC's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does PETS pay a dividend, and is it safe?

Yes. PETMED EXPRESS INC pays a dividend yielding about 0.06% with a 0.0% payout ratio, rated “safe” for safety.

How profitable is PETS?

In FY2026, PETMED EXPRESS INC had a net margin of -32.0% and a return on equity of -197.9%.

Is PETS overvalued or undervalued?

PETMED EXPRESS INC trades at about 8.0× trailing earnings — below its 10-year norm (10-year range 11.9×–61.5×, median 19.4×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for PETS?

The average Wall-Street price target for PETMED EXPRESS INC is $2.15, about 7.0% above the recent price, from 1 analysts.

Is PETS a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on PETMED EXPRESS INC: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone, a dividend yield of 0.06%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.